Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
10.1038/ncomms3976 · doi-reference
Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the Hippo pathway for the treatment of esophageal squamous cell carcinoma
10.1016/j.ejmech.2025.117328 · doi-reference
Targeting YAP/TAZ–TEAD and their protein-protein interaction for precision cancer therapy
10.1016/j.ejmech.2025.118330 · doi-reference
NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo
10.1016/j.stem.2024.03.003 · doi-reference
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
10.1101/gad.192856.112 · doi-reference
Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)
10.1080/13543776.2022.2096436 · doi-reference
YAP represses intestinal inflammation through epigenetic silencing of JMJD3
10.1186/s13148-024-01626-w · doi-reference
YAP activates STAT3 signalling to promote colonic epithelial cell proliferation in DSS-induced colitis and colitis associated cancer
10.2147/jir.s377077 · doi-reference
Microvascular endothelial cells license APS vasculopathy through YAP1- and CCN2-mediated signaling
10.1161/circulationaha.125.073552 · doi-reference
Role of the Hippo pathway in autoimmune diseases
10.1016/j.exger.2023.112336 · doi-reference
Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis
10.1136/annrheumdis-2021-220875 · doi-reference
Regulation of photosensitivity by the Hippo pathway in lupus skin
10.1002/art.42460 · doi-reference
YAP1 overexpression is associated with kidney dysfunction in lupus nephritis
10.1159/000517575 · doi-reference
Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
10.1002/art.34477 · doi-reference
YAP/TAZ: key players for rheumatoid arthritis severity by driving fibroblast like synoviocytes phenotype and fibro-inflammatory response
10.3389/fimmu.2021.791907 · doi-reference
Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis
10.1016/j.ard.2025.11.027 · doi-reference
Type I interferons in autoimmunity: implications in clinical phenotypes and treatment response
10.3899/jrheum.2022-0827 · doi-reference
miR21 modulates the Hippo signaling pathway via interference with PP2A Bβ to inhibit trophoblast invasion and cause preeclampsia
10.1016/j.omtn.2022.09.006 · doi-reference
Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population
10.1016/j.preghy.2019.11.002 · doi-reference
The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts
10.1073/pnas.2425339122 · doi-reference
The Hippo pathway component Wwc2 is a key regulator of embryonic development and angiogenesis in mice
10.1038/s41419-021-03409-0 · doi-reference
Hippo signaling cofactor, WWTR1, at the crossroads of human trophoblast progenitor self-renewal and differentiation
10.1073/pnas.2204069119 · doi-reference
Pivotal role of the transcriptional co-activator YAP in trophoblast stemness of the developing human placenta
10.1073/pnas.2002630117 · doi-reference
Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy
10.1016/j.humimm.2021.01.004 · doi-reference
The interplay between hippo signaling and mitochondrial metabolism: implications for cellular homeostasis and disease
10.1016/j.mito.2024.101885 · doi-reference
Interplay between YAP/TAZ and metabolism
10.1016/j.cmet.2018.07.010 · doi-reference
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
10.1038/nature13545 · doi-reference
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
10.1038/s41467-022-28691-0 · doi-reference
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer
10.1016/j.molcel.2019.06.010 · doi-reference
Crosstalk between YAP/TAZ and ERα in mechanical and hormonal signaling in the skeletal system
10.3724/abbs.2025186 · doi-reference
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies
10.1038/ng.714 · doi-reference
Hippo-vgll3 signaling may contribute to sex differences in Atlantic salmon maturation age via contrasting adipose dynamics
10.1186/s13293-025-00705-8 · doi-reference
Food quality and life-history genotype influence maturation and reproductive traits in female Atlantic salmon
10.1111/mec.17735 · doi-reference
Sex-dependent dominance at a single locus maintains variation in age at maturity in salmon
10.1038/nature16062 · doi-reference
Vgll3 and the Hippo pathway are regulated in Sertoli cells upon entry and during puberty in Atlantic salmon testis
10.1038/s41598-018-20308-1 · doi-reference
Sex differences in autoimmune disease from a pathological perspective
10.2353/ajpath.2008.071008 · doi-reference
Why women have more autoimmune diseases than men: an evolutionary perspective
10.1111/eva.13167 · doi-reference
YAP aggravates inflammatory bowel disease by regulating M1/M2 macrophage polarization and gut microbial homeostasis
10.1016/j.celrep.2019.03.028 · doi-reference
The Hippo signaling network and its biological functions
10.1146/annurev-genet-120417-031621 · doi-reference
Regulatory mechanism of macrophage polarization based on Hippo pathway
10.3389/fimmu.2023.1279591 · doi-reference
